These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20093428)

  • 1. Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.
    Brims DR; Qian J; Jarchum I; Mikesh L; Palmieri E; Ramagopal UA; Malashkevich VN; Chaparro RJ; Lund T; Hattori M; Shabanowitz J; Hunt DF; Nathenson SG; Almo SC; Dilorenzo TP
    Int Immunol; 2010 Mar; 22(3):191-203. PubMed ID: 20093428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
    J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4.
    Takaki T; Lieberman SM; Holl TM; Han B; Santamaria P; Serreze DV; DiLorenzo TP
    J Immunol; 2004 Aug; 173(4):2530-41. PubMed ID: 15294969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Niens M; Kulik J; Dilorenzo TP
    Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
    Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice.
    Marron MP; Graser RT; Chapman HD; Serreze DV
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13753-8. PubMed ID: 12361980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation.
    Roden MM; Brims DR; Fedorov AA; DiLorenzo TP; Almo SC; Nathenson SG
    Mol Immunol; 2006 Mar; 43(9):1370-8. PubMed ID: 16229893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.
    Matsumoto Y; Kishida K; Matsumoto M; Matsuoka S; Kohyama M; Suenaga T; Arase H
    Biochem Biophys Res Commun; 2021 Jan; 534():680-686. PubMed ID: 33208230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression.
    Schloss J; Ali R; Racine JJ; Chapman HD; Serreze DV; DiLorenzo TP
    J Immunol; 2018 May; 200(10):3353-3363. PubMed ID: 29632144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
    Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
    Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells.
    Morgan DJ; Nugent CT; Raveney BJ; Sherman LA
    J Immunol; 2004 Jan; 172(2):1000-8. PubMed ID: 14707073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
    Serreze DV; Niens M; Kulik J; DiLorenzo TP
    Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
    Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
    Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus.
    Wong FS; Moustakas AK; Wen L; Papadopoulos GK; Janeway CA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5551-6. PubMed ID: 11943852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.